Covid-19: monoclonal antibody (MAB) therapeutic sotrovimab
Ended Definitive Contract Awarded Last action
- Contract number
- W58P0521C0008
- Awardee
-
Glaxosmithkline, LLC UEI FRHTPHMZMX47
- Awarding agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Obligated
- $279,862,800
Award facts
- Contract value 100% obligated
- $279,862,800.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27709, USA
- Legislative mandates
-
- Economy Act FAR subpart 17.5
- National interest action
- Coronavirus COVID-19
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $279,862,800 |
About this award
The Department of the Army awarded a definitive contract valued at approximately $280 million to Glaxosmithkline, LLC for the delivery of COVID-19 monoclonal antibody therapeutic sotrovimab. The firm fixed price contract runs from September 2021 through May 2022 for research and distribution services to be performed in Research Triangle Park, North Carolina. Glaxosmithkline will provide the therapeutic to treat Coronavirus COVID-19, as identified in the national interest action code. ASD Specialty Healthcare, LLC will serve as the major subcontractor, managing order intake, state allocation, product storage, shipping, and data related to distribution of the therapeutic. No set aside designation was indicated.
Quick answers
Who was awarded contract W58P0521C0008?
W58P0521C0008 was awarded to Glaxosmithkline, LLC by ACC Aberdeen Proving Ground (Army Contracting Command) on September 24, 2021.
How much is contract W58P0521C0008 worth?
The government has obligated $279,862,800 on W58P0521C0008.
Which agency awarded contract W58P0521C0008?
ACC Aberdeen Proving Ground (Army Contracting Command) awarded W58P0521C0008, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).
Was contract W58P0521C0008 competed?
The extent of competition for W58P0521C0008 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award